JP2022550316A5 - - Google Patents
Info
- Publication number
- JP2022550316A5 JP2022550316A5 JP2022518946A JP2022518946A JP2022550316A5 JP 2022550316 A5 JP2022550316 A5 JP 2022550316A5 JP 2022518946 A JP2022518946 A JP 2022518946A JP 2022518946 A JP2022518946 A JP 2022518946A JP 2022550316 A5 JP2022550316 A5 JP 2022550316A5
- Authority
- JP
- Japan
- Prior art keywords
- ehd2
- domain
- amino acid
- modified
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025014991A JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ｅｈｄ２ドメインを含む結合モジュール |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19199639.6 | 2019-09-25 | ||
| EP19199639 | 2019-09-25 | ||
| PCT/EP2020/077008 WO2021058804A1 (en) | 2019-09-25 | 2020-09-25 | Binding modules comprising modified ehd2 domains |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025014991A Division JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ｅｈｄ２ドメインを含む結合モジュール |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550316A JP2022550316A (ja) | 2022-12-01 |
| JP2022550316A5 true JP2022550316A5 (https=) | 2023-04-18 |
Family
ID=68109107
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518946A Pending JP2022550316A (ja) | 2019-09-25 | 2020-09-25 | 修飾ｅｈｄ２ドメインを含む結合モジュール |
| JP2025014991A Withdrawn JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ｅｈｄ２ドメインを含む結合モジュール |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025014991A Withdrawn JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ｅｈｄ２ドメインを含む結合モジュール |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220372147A1 (https=) |
| EP (1) | EP4034244A1 (https=) |
| JP (2) | JP2022550316A (https=) |
| KR (1) | KR20220071210A (https=) |
| CN (1) | CN115066275A (https=) |
| AU (1) | AU2020356407A1 (https=) |
| CA (1) | CA3155725A1 (https=) |
| MX (1) | MX2022003507A (https=) |
| WO (1) | WO2021058804A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4454706A1 (en) | 2023-04-24 | 2024-10-30 | Universität Stuttgart | Novel egfr binding proteins |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| AU2009303318B2 (en) * | 2008-10-10 | 2016-06-30 | Aptevo Research And Development Llc | TCR complex immunotherapeutics |
| CA2785907A1 (en) * | 2009-12-29 | 2011-07-28 | Emergent Product Development Seattle, Llc | Ron binding constructs and methods of use thereof |
| WO2012158818A2 (en) * | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| WO2013075027A2 (en) * | 2011-11-17 | 2013-05-23 | Emergent Product Development Seattle, Llc | Anti-sil6xr complex binding domains and methods of use |
| WO2013156054A1 (en) * | 2012-04-16 | 2013-10-24 | Universität Stuttgart | The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity |
| BR112017009277A2 (pt) * | 2014-11-14 | 2017-12-19 | Procter & Gamble | compostos de silicone |
| US10428149B2 (en) * | 2015-03-18 | 2019-10-01 | Universitat Stuttgart | Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof |
| WO2017011342A1 (en) * | 2015-07-10 | 2017-01-19 | Abbvie Inc. | Igm-or-ige-modified binding proteins and uses thereof |
| WO2017106462A1 (en) * | 2015-12-18 | 2017-06-22 | Biogen Ma Inc. | Bispecific antibody platform |
| WO2018037092A1 (en) * | 2016-08-26 | 2018-03-01 | Sanofi | Multispecific antibodies facilitating selective light chain pairing |
| BR112019005001A2 (pt) * | 2016-09-15 | 2019-06-04 | Universität Stuttgart | proteína de ligação ao antígeno, proteína de fusão, ácido nucleico, vetor recombinante, célula hospedeira recombinante, composição farmacêutica, uso médico da proteína de ligação ao antígeno e método de inibição do crescimento tumoral |
| AU2018414456B2 (en) * | 2018-03-22 | 2025-09-11 | Universität Stuttgart | Multivalent binding molecules |
| CN115066274A (zh) * | 2019-09-25 | 2022-09-16 | 斯图加特大学 | 三价结合分子 |
| BR112022017048A2 (pt) * | 2020-02-26 | 2022-11-16 | Vir Biotechnology Inc | Anticorpos contra sars-cov-2 e métodos para usar os mesmos |
| JP2023521418A (ja) * | 2020-04-10 | 2023-05-24 | インビビド， インコーポレイテッド | コロナウイルスｓタンパク質に特異的な化合物及びその使用 |
| EP4228697A4 (en) * | 2020-10-16 | 2025-01-01 | Invisishield Technologies Ltd. | Compositions for preventing or treating viral and other microbial infections |
-
2020
- 2020-09-25 MX MX2022003507A patent/MX2022003507A/es unknown
- 2020-09-25 EP EP20785700.4A patent/EP4034244A1/en active Pending
- 2020-09-25 KR KR1020227012195A patent/KR20220071210A/ko active Pending
- 2020-09-25 AU AU2020356407A patent/AU2020356407A1/en active Pending
- 2020-09-25 CA CA3155725A patent/CA3155725A1/en active Pending
- 2020-09-25 CN CN202080082634.XA patent/CN115066275A/zh active Pending
- 2020-09-25 US US17/762,463 patent/US20220372147A1/en active Pending
- 2020-09-25 WO PCT/EP2020/077008 patent/WO2021058804A1/en not_active Ceased
- 2020-09-25 JP JP2022518946A patent/JP2022550316A/ja active Pending
-
2025
- 2025-01-31 JP JP2025014991A patent/JP2025081354A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7001474B2 (ja) | 非免疫原性単一ドメイン抗体 | |
| Mochly-Rosen et al. | Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site | |
| JP7486810B2 (ja) | ＩｇＧ１ Ｆｃモノマー、及びその使用 | |
| JP2023504914A5 (https=) | ||
| CN111606995B (zh) | 抗人pd-l1单克隆抗体及其应用 | |
| JP2020500510A5 (https=) | ||
| JP2014518883A5 (https=) | ||
| US11505601B2 (en) | Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum | |
| JP2010539921A5 (https=) | ||
| EP2855518A1 (en) | P2x7 receptor antagonists and agonists | |
| CN109705213B (zh) | 抗金黄色葡萄球菌毒素抗体及其用途 | |
| JP2019058160A (ja) | ヒトｐ１８５及び血管内皮増殖因子の両方を標的とする抗体及びその適用 | |
| TW202241947A (zh) | 包含靶向磷脂醯肌醇蛋白聚糖—３和ｔ細胞受體的免疫球蛋白單可變結構域的多肽 | |
| FR2974816A1 (fr) | Methode de generation de proteines | |
| CN105829889A (zh) | 用于测定多价、多特异性分子的生物活性的基于spr的桥接测定法 | |
| CN102703388A (zh) | 抗人mCRP蛋白的单克隆抗体、杂交瘤细胞系和试剂盒 | |
| JP2023553694A5 (https=) | ||
| CN102746403A (zh) | 用于elisa检测黄曲霉毒素的标准品通用替代物、其制备方法及黄曲霉毒素elisa检测方法 | |
| JP2022550316A5 (https=) | ||
| Reese et al. | Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands | |
| CN110878124B (zh) | Dna聚合酶的抗体片段、抗体及其应用 | |
| JP2024503425A5 (https=) | ||
| Marchalonis et al. | Antigenic cross-reactions among immunoglobulin of diverse vertebrates (elasmobranchs to man) detected using xenoantisera | |
| Mustafaev et al. | Immune response to progesterone involved in Cu2+-mediated polyanion-protein complex—antigen specificity and affinity of hybridoma clones | |
| CN102321177A (zh) | 一种抗三聚氰胺单链抗体及其应用体 |